FDA Inspection 1027413 — Center for Fertility and Reproductive Endocrinology UPP

Center for Fertility and Reproductive Endocrinology UPP — FEI 3004081056

The FDA completed an inspection of Center for Fertility and Reproductive Endocrinology UPP on August 29, 2017 in Pittsburgh, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 29, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Pittsburgh, PA (United States)